ArticleEuropean journal of hospital pharmacy : science and practice2019

Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?

Antonella Nappi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.